Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Linyun Pharmaceutical is a specialized pharmaceutical company based in Chongqing, China, operating as a wholly-owned subsidiary of Pharscin Pharmaceutical. The company focuses on the research, development, and large-scale manufacturing of chemical drugs, particularly in the therapeutic areas of gastroenterology, cardiovascular health, and psychiatry. As a key manufacturing arm for the Pharscin group, Linyun Pharmaceutical operates high-standard production facilities that comply with Chinese GMP requirements. The company supports the parent group's transition from traditional generics to innovative small molecule drug development. Its portfolio includes several market-leading products in the Chinese domestic market, such as treatments for acid-related disorders and hypertension.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Linyun Pharmaceutical.